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ABSTRACT. We will study a mathematical model of the human immunodeficiency virus (HIV) infection in the
presence of combination therapy that includes within-host infectious dynamics. The deterministic model requires
us to analyze asymptotic stability of two distinct steady states, disease-free and endemic equilibria. Previous results
have focused on investigating the global asymptotic stability of the trivial steady state using an implicit finite-
difference method which generates a system of difference equations. We, instead, provide analytic solutions and
long term attractive behavior for the endemic steady state using the theory of difference equations. The dynamics
of estimated model is appropriately determined by a certain quantity threshold maintaining the immune response
to a sufficient level. The result also indicates that a forward bifurcation in the model happens when the disease-free
equilibrium loses its stability and a stable endemic equilibrium appears as the basic reproduction number exceeds
unity. In this scenario, the classical requirement of the reproduction number being less than unity becomes a
necessary and sufficient condition for disease mitigation. When the associated reproduction number is in excess of
unity, a stable endemic equilibrium emerges with an unstable disease-free equilibrium (leading to the persistence
and existence of HIV within the infected individuals). The attractivity of the model reveals that the disease-free
equilibrium is globally asymptotically stable under certain assumptions. A comparison between the continuous and
estimated discrete models is also provided to have a clear perception in understanding the behavioral dynamics of
disease modelling. Finally, we show that the associated estimation method is very robust in the sense of numerical
stability since the equilibria and the stability conditions are independent of the time step.
1. INTRODUCTION
Although rising number of anti-HIV (human immunodeficiency virus) preventive vaccines (also prophylactic
vaccines) currently undergo clinical trials (see [1] and the references therein), there has been a surge of interest
during the past decades with regards to mathematical model for HIV infection in order to determine the side
effects and long term impacts of such vaccines to the community. Identifying an optimal treatment therapy to
minimize the viral load still poses significant threats to the human beings and a dilemma for public health policy
maker [27, 24, 19, 36]. In particular, since none of the current anti-HIV vaccines attains high enough efficacy
to prevent HIV infection, such models may give insight into the optimal efficacy and treatment coverage levels
needed to mitigate HIV infection in the community [1].
Although some published papers concerning the HIV infection models provides mostly slight details on
the system of difference equations extracted from associated systems of differential equations, authors have
thoroughly studied this subject [6, 9, 12, 18, 32, 39, 43]. Besides, there are outstanding published papers in the
mathematical literature in the field of difference equations while a few of them discussed systems of difference
equations with two equations or more than one equilibrium point [2, 33, 45, 48, 52]. Implementation of control
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theory to infectious diseases is another challenge to alleviate infection widespread. For instance, Jaberi et
al. [19] developed an optimal control theory to a population model for influenza infection with sensitive and
resistant strains and solved the adjoint control components to find the optimal treatment profile that reduces the
epidemic final size. In the current research work, however, we attempt to analyze and mitigate a HIV infection
presented by a model of difference equations with three equations associated with two distinct equilibrium
points.
Apart from impede and enhance performance in mathematical analysis, several challenges related to the
characteristics of the pathogen, e.g. replication and evolution, have been encountered the nature of host immune
responses at the individual level [1, 2, 11, 13, 14, 37]. The viral replication is essential for progression of HIV
to AIDS and, as a result, requires better administration and intervention of antiretroviral drugs [29, 30, 31, 38].
The replication process of the HIV pathogen undergo a cycle of development within a human host. Several
essential phases (enzymes) such as reverse transcriptase, protease, ribonuclease and integrase are required for
successful development of infectious virus particle [1, 2, 11, 13, 14, 31, 38]. In most cases these replication
process are taken into consideration and mathematically formulated by different types of population models
using differential equations. Generally speaking, a handful of these models underwent analytic approaches to
investigate the sensitivity and stability analysis. Other approaches, mostly computational, have been taken into
account to determine the most efficient way of drug treatment at both the individual and population levels [14].
Not surprisingly, some mathematical models dealing with a nonlinear IVP (initial value problem) system do
not have a closed form solution, nor can one, even locally, predict the long-term behavior of infection. As a
result, a numerical method (e.g. see section 3.2) is widely applied to observe the characteristics of the system
with various effects of time steps, especially for artificially large time steps. However, one may argue that if a
numerical method is applied to a system of differential equations, the solution obtained through the numerical
scheme may be inconsistent with the original system. An appropriate explanation to this argument will be
provided in section 5.1.
The outline of current paper is organized as follows. Our main purpose in this work is to study the stability
and bifurcation of the existing mathematical model for HIV infection
T ′4(t) = (s+ r T4(t)VI(t))− kv (1− ERT ) (r + α)T4(t)VI(t)− γ1 T4(t), T4(t0) = T
0
4 , (1.1)
T ′I(t) = (kv (1− ERT ) (r + α))T4(t)VI(t)− (γ2 + kc)TI(t), TI(t0) = T
0
I , (1.2)
V ′I (t) = γ2 (1− EPI)N (1− L)TI(t)− σ VI(t), VI(t0) = V
0
I , (1.3)
where the parameters are given in Table 1. We will investigate the long term behavior of solutions in two
different scenarios, continuous and discrete forms. A system of difference equations will be obtained from
discretization of the mathematical model. It will be shown that the estimation method used in [14] to discretize
system (1.1)–(1.3) is significantly compatible with the continuous system and is a robust numerical method to
investigate the nature of the IVP system (for instance, see [39]), that is, we can obtain similar properties (such
as boundedness, asymptotic stability, oscillatory behavior) of the IVP system from the associated numerical
scheme. It is worthwhile to point out that we demonstrate the condition for the endemic equilibrium point of
the discrete model to be stable is given by e > (b− 1)(1− d)(1− f) which was conjectured in [44] as an Open
Problem, i.e. the associated reproduction number is greater than unity for stable endemic state. Similarities and
differences between two models are reported in the beginning of Section 4. This research ends with extensive
simulations and a brief conclusion.
2. A SURVEY ON MATHEMATICAL MODEL AND DYNAMICS OF CONTINUOUS SYSTEM
The viral replication is essential for progression of HIV to AIDS and, as a result, requires better adminis-
tration and intervention of antiretroviral drugs [29, 30, 31, 38]. The replication process of the HIV pathogen
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undergo a cycle of development within a human host. Several essential phases (enzymes) such as reverse
transcriptase, protease, ribonuclease and integrase are required for successful development of infectious virus
particle [1, 2, 11, 13, 14, 31, 38]. Each step is therefore a potential target for identification of an optimal treat-
ment therapy. In the first step, infectious virus particles locate appropriate host cells such as a CD4+ T cells
to infect. The process of infection begins by entering HIV into the target cell by fusion after binding to the
CD4 glycoprotein and then releasing three crucial replication enzymes: Reverse Transcriptase, Integrase and
Protease. Prophylactic medications which interfere with the principal stages of viral replication can inhibit this
mortal contamination. For instance, introduction of HIV into the recipient cell which involves in initial infec-
tion can be possibly impeded by implementation of fusion inhibitors. Mitigation of reverse transcriptase by
application of nucleoside inhibitors or by non-nucleoside Reverse Transcriptase inhibitors is also part of stan-
dard therapeutic course of medical treatments. Besides, the fatal process of Retroviral Integrase which enables
the genetic material of retrovirus enzyme to be integrated into the DNA of the infected cell can be blocked by
HIV integrase inhibitors such as Raltegravir [53]. Perhaps the last key step in a standard antiretroviral therapy
is to inhibit the retroviral aspartyl protease causing disease progression by intervention of protease inhibitors
including Saquinavir, Ritonavir, Indinavir, Nelfinavir, Amprenavir [50].
The model simulates the interaction between CD4+ T-lymphocyte (these cells perform essential helper func-
tions in the development of cellular and humoral immunity against pathogens including HIV, see [11, 13, 14])
and HIV in vivo when combination antiretroviral therapy is used. Namely, reverse transcriptase (RT) inhibitors
and protease inhibitors (PIs) as antiviral drug intervention are exerted for the perturbation of HIV infection.
Parameter Interpretation Value
s Source term for uninfected CD4+ T cells 8.076 d−1mm−3
r Rate of proliferation of CD4+ T cells 0.03 d−1
kv Probability of infection of activated CD4
+ T cells 1
γ1 Natural death rate of uninfected CD4
+ T cells 0.5 d−1
γ2 Natural death rate of infected CD4
+ T cells 0.5 d−1
kc Anti-HIV immune response 0.5
N Number of free viruses produced per infected cell 1000
L Proportion of latently infected T cells 0.2
ERT Effectiveness of RT inhibitors 0 < ERT < 1
EPI Effectiveness of protease inhibitors 0 < EPI < 1
σ Rate of clearance of infectious virions 10 d−1
α Proportion of pre-existing activated CD4+ T cells 0 < α < 1
TABLE 1. Description of parameters in HIV model and their estimated values [8, 14, 44]
The existing mathematical model will be briefly described in the sequel, for further information and the
terminology used here, we refer readers to [14, 43, 44, 46]. The experiment shows that the reciprocal interplay
between infectious viral particles and CD4+ T cells produces three sizable quantities in vivo which are charac-
terized by the mathematical notations: T4, TI , and VI , where the variable T4 is used to illustrate the amount of
inactivated CD4+ T cells at each unit of time which is not accompanied by integrated HIV (or susceptible cells
in patient), the second quantity TI is taken into consideration to represent the amount of CD4
+ T cells carrying
integrated HIV (infected cells), and the third class VI indicates infectious HIV load (infectious particles) re-
leased from infected cells. As depicted in Figure 1, a compartmental model is used to facilitate the flow in each
category and the interaction between CD4+ T cells and viral particles with the intervention of combination
antiretroviral therapy. Using the three compartments illustrated for the sizable amount of susceptibles, infected
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CD4+T Cells (Susceptible)
Infected cells carrying
integrated HIV (Infected)
Infectious virus par-
ticles (Infectious)
dT4
dt
= (s+ r T4 VI)− λ1 T4 VI − γ1 T4,
dTI
dt
= λ1 T4 VI − (γ2 + kc)TI ,
dVI
dt
= λ2 TI − σ VI ,
Source
λ1 = (r + α)(1− ERT )kv
γ1
kc
σ
λ2 = γ2(1− EPI)N(1− L)
FIGURE 1. Compartmental model of HIV infection for three different cell types, i.e. susceptible, infected, and
infectious. In this model, λ1 and λ2 are the force of infection from the susceptible compartment to the infected one
and the force of infection from the infected compartment to the infectious one, respectively.
cells and free virions, we obtain the following associated IVP system at any time t, t > t0,
dT4
dt
= (s+ r T4(t)VI(t))− λ1 T4(t)VI(t)− γ1 T4(t),
= s+ e1 T4(t)VI(t)− γ1 T4(t), T4(t0) = T
0
4 , (2.1)
dTI
dt
= e2 T4(t)VI(t)− e3 TI(t), TI(t0) = T
0
I , (2.2)
dVI
dt
= e4 TI(t)− σ VI(t), VI(t0) = V
0
I , (2.3)
where the recruitment term (s+ r T4(t)VI(t)) represents the autocatalysis (autocatalytic reaction in a chemical
reaction was also examined by Petrov et al. [49], see also [42], with cubic and quadratic autocatalysis term)
and the parameters are given in Table 1 and defined by
e1 = r − kv (1− ERT ) (r + α) and e2 = kv(1−ERT ) (r + α);
e3 = γ2 + kc and e4 = γ2 (1− EPI)N (1− L).
(2.4)
Note that the infection term is given by λ1 in Figure 1, not by e1. As a result, the law of conservation of mass
will remain constant over time, that is, the population mass leaving the susceptible (healthy) compartment is
taken into account in the succeeding compartment regarded as infected cells carrying integrated virus particles.
For the simplicity in analysis of system (2.1)−(2.3) and comparative presentation, we add together r and kv (1−
ERT ) (r + α) and use the notation e1.
The following change of variables simplifies the model (2.1)−(2.3), where e1 6= 0:
T4 =
s
γ1
x, TI =
e2 s
|e1| γ1
y, and VI =
e2 e4 s
|e1| e3 γ1
z. (2.5)
In fact, the system of differential equations (2.1)−(2.3) takes the following form:
x′ = F (x, z) = sign(e1) ρ x z + τ − τ x, x(0) = x0,
y′ = G(x, y, z) = ρ x z − ζ y, y(0) = y0, (2.6)
z′ = H(y, z) = ζ y − η z, z(0) = z0,
in which τ = γ1, ρ =
e2 e4 s
e3 γ1
, ζ = e3, η = σ, and sign(·) is the signum function of real numbers. It is
worthwhile to mention that solutions of system (2.6) is positively invariant with respect to the first octant, i.e.
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R
3
+ = {(x, y, z)|x ≥ 0, y ≥ 0, z ≥ 0}, [8]. The equilibria of system (2.6),
E1 = (1, 0, 0) and E2 =
(
η
ρ
,
τ (η − ρ)
sign(e1) ρ ζ
,
τ (η − ρ)
sign(e1) ρ η
)
. (2.7)
can easily be evaluated by some algebraic calculation. Now set Rc = ρ/η. The quantity Rc is the basic
reproduction number for the continuous model (2.6). Note that if Rc = 1, then the system (2.6) has no
equilibria other than E1. To investigate the local asymptotic stability, we evaluate the characteristic poly-
nomial by first differentiating the right-hand side of (2.6) and then calculating the Jacobian matrix at the
equilibria [17, 40, 47]. The characteristic polynomial at the disease-free equilibrium, E1, is given by −(λ +
τ)
[
λ2 + (ζ + η)λ+ ζ(η − ρ)
]
, and the characteristic polynomial at the endemic state, E2, is presented by
− λ3 −
(
ζ + η +
τ ρ
η
)
λ2 −
(
τ ρ+
τ ρ ζ
η
)
λ− τ ζ (ρ− η). (2.8)
Using the Routh-Hurwitz criterion [40] for the above characteristic polynomials, one can show [8, 14] that the
disease-free state E1 is locally asymptotically stable if Rc < 1 and is unstable if Rc > 1. Also for the latter
case, the endemic state E2 is locally asymptotically stable and is unstable if Rc < 1. In addition, the system
has no equilibria other than E1 when Rc = 1. The eigenvalues of the Jacobian matrix at the disease-free
state are {0,−τ,−ζ − η}. It was shown (see Theorem 3.4 in [8]) that if e1 > 0 and Rc > 1, it follows that
(x, y, z) → (∞,∞,∞) for (x0, y0, z0) ∈ ∆ = {(x, y, z) | y 6= 0 or z 6= 0} ∩ R
3
+. It was also illustrated by
some experiments in [8] that system (2.6) has bounded and unbounded solutions depending on the domain of
initial values when e1 > 0 and Rc ≥ 1, while the following result shows the stability of steady states when
e1 < 0 (see Theorems 4.1, 4.11 and Remark 4.2 in [8]).
Theorem 2.1. Consider system (2.6) with e1 < 0. Then the following statements are true.
(i) If the reproduction number Rc is less than or equal to unity, then the disease-free state is globally
asymptotically stable in R3+. In this case, HIV infection is eradicated from the infected host.
(ii) If the reproduction number Rc is greater than unity, then the endemic state is globally asymptotically
stable in ∆. This case leads to the persistence and existence of HIV infection within the individual.
Considering system (2.1)−(2.3) with e1 = 0, it follows that the equilibrium point (s/γ1, 0, 0) is unique
when w = C e3 γ1 − s e2 e4 6= 0. When w = 0, the model (2.1)−(2.3) also possesses the unique positive
equilibrium (s/γ1, e4 θ/C, θ), in which θ depends critically on the coefficients of the system and the initial
value (x0, y0, z0). The following theorem shows the qualitative behavior of system (2.1)−(2.3) when e1 = 0.
Theorem 2.2 (See [8]). Consider system (2.1)−(2.3) with e1 = 0. Then the following statements are true.
(i) If w > 0, then the disease-free state is globally asymptotically stable in R3+.
(ii) If w = 0, then positive solutions converges eventually to (s/γ1, e4 θ/C, θ) when (T
0
4 , T
0
I , V
0
I ) ∈ R
3
+.
The model (2.1)−(2.3) has unbounded solutions whenever e1 = 0 and w < 0 (see Remark 5.4 and examples
illustrated in [8]).
3. ANALYSIS OF DISCRETE MODEL
3.1. Preliminaries to difference equations. In this part, we begin by presenting some basic definitions to
study the qualitative behavior of a system of difference equations. Let I1, I2, and I3 be some intervals of real
numbers and let
Fi : I1 × I3 × I3 −→ Ii, for i ∈ {1, 2, 3}
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be three continuously differentiable functions. Then for every initial condition (x0, y0, z0) ∈ I1 × I2 × I3, the
system of difference equations
xn+1 = F1(xn, zn), yn+1 = F2(xn+1, yn, zn), zn+1 = F3(yn+1, zn) (3.1)
has a unique solution {(xn, yn, zn)}
∞
n=0. A point (x¯, y¯, z¯) ∈ I1 × I2 × I3 is called an equilibrium point of
system (3.1) if
x¯ = F1(x¯, z¯), y¯ = F2(x¯, y¯, z¯), z¯ = F3(y¯, z¯). (3.2)
Definition 3.1. The equilibrium point (x¯, y¯, z¯) of system (3.1) is called
(1) stable (or locally stable) if for every ǫ > 0, there exists δ > 0 such that for all (x0, y0, z0) ∈ I1×I2×I3
with ‖(x0, y0, z0)− (x¯, y¯, z¯)‖ < δ implies ‖(xn, yn, zn) − (x¯, y¯, z¯)‖ < ǫ for all n ≥ 0. Otherwise the
equilibrium point is called unstable.
(2) asymptotically stable (or locally asymptotically stable) if it is stable and there exists γ > 0 such that
for all (x0, y0, z0) ∈ I1 × I2 × I3 with ‖(x0, y0, z0)− (x¯, y¯, z¯)‖ < γ implies limn→∞ ‖(xn, yn, zn)−
(x¯, y¯, z¯)‖ = 0.
(3) globally asymptotically stable if it is locally stable and for every (x0, y0, z0) ∈ I1 × I2 × I3, we have
‖(xn, yn, zn)− (x¯, y¯, z¯)‖ → 0, as n→∞.
(4) a repeller, if there exists r > 0 such that for all (x0, y0, z0) ∈ I1 × I2 × I3 with 0 < ‖(x0, y0, z0) −
(x¯, y¯, z¯)‖ < r, there exists N ≥ 1 such that ‖(xN , yN , zN )− (x¯, y¯, z¯)‖ ≥ r.
3.2. Discretizing the model. Here, we investigate the boundedness, the stability analysis, and the bifurcation
phenomenon of a discrete system in general cases. The development of the numerical method will be based on
the first-order approximation and using a numerical method of the form [14, 39, 41, 54, 55, 56, 22, 23, 25, 26]
W n+1 = W n + l f(W n,W n+1), n ≥ 0 (3.3)
whereW n = [T n4 , T
n
I , V
n
I ]
⊤, ⊤ denoting transpose. The robust numerical method can be obtained by approx-
imating the time derivative with its first-order forward-difference approximation for each equation in the left
side of system (2.1)−(2.3) and making appropriate estimations for the right side, as follows with the fixed time
step size ℓ > 0.
(T n+14 − T
n
4 )/ℓ = s+ e1 T
n+1
4 V
n
I − γ1 T
n+1
4 , (3.4)
(T n+1I − T
n
I )/ℓ = e2 T
n+1
4 V
n
I − e3 T
n+1
I , (3.5)
(V n+1I − V
n
I )/ℓ = e4 T
n+1
I − σ V
n
I . (3.6)
Note that the variables T n4 , T
n
I , and V
n
I denote the estimation values of T4(nℓ), TI(nℓ), and VI(nℓ) respectively.
In addition, T n4 , T
n
I , and V
n
I are taken into consideration as a set with three non-negative sequences consistent
with the biological nature of the model in practice. In fact, the parameters of the model should be chosen
such that T n4 , T
n
I , and V
n
I are non-negative. In most cases, the non-negativity is a standard assumption in the
literature of difference equations [7, 18, 33, 34], besides the nature of the model (the IVP system) is another
reason. Note also that it is a very difficult task to investigate [9] the behavior of solutions of a difference
equation which attains negative and positive values simultaneously. For instance, finding a forbidden set, the
set of initial conditions through which the related difference equation is undefined, is a difficult task for this
class of difference equations. To observe these types of complexities, readers are encouraged to study ([34],
p.17). However, in this work we will obtain some results where cˆ > 0 in Equation (3.4), that is, the solutions
of system (3.4)−(3.6) deal with negative numbers, see Appendix A.
Using the following change of variables
T n4 = l s xn, T
n
I = (1 + l σ) yn/l e4, V
n
I = zn, (3.7)
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and re-arranging system (3.4)−(3.6), it follows that
xn+1 =
1 + xn
b+ c zn
, (3.8)
yn+1 = d yn + e xn+1 zn, (3.9)
zn+1 = f zn + yn+1, (3.10)
where b = 1 + l γ1 > 1, c = −l e1 ∈ R, 0 < d = (1 + l e3)
−1 < 1, e = l3s e4 e2 ((1 + l e3)(1 + l σ))
−1 > 0,
and 0 < f = (1 + l σ)−1 < 1.
Define Rd = e/ ((b− 1) (1 − d) (1 − f)), the threshold Rd is the basic reproduction number for discrete
model (3.8)−(3.10). Suppose that c 6= 0 and Rd 6= 1, then it is easy to show that system (3.8)−(3.10),
independent of time step size, has the disease-free equilibrium point(
(b− 1)−1, 0, 0
)
, (3.11)
and the endemic equilibrium point(
(1− d) (1 − f)
e
,
e+ (1− b) (1− d) (1 − f)
c (1 − d)
,
e+ (1− b) (1 − d) (1 − f)
c (1 − d) (1 − f)
)
. (3.12)
Note that system (3.8)−(3.10) has only one equilibrium point (3.11) where either c 6= 0 or Rd 6= 1. We also
observe that system (3.8)−(3.10) has the following equilibrium point (1/(b − 1), (1 − f)ψ,ψ), where c = 0
and Rd = 1, in which ψ depends on the coefficients of system (3.8)−(3.10) and the initial value (x0, y0, z0).
The following theorem provides us the boundedness of solutions which will be trapped into some intervals.
Theorem 3.2 (See [44], Section 4.1). Let b > 1, c > 0, 0 < d < 1, e > 0 and 0 < f < 1. Then either
(xn, yn, zn) converges to an equilibrium point or the following statements are true.
Γ ≤ lim inf xn ≤ lim supxn ≤ (b− 1)
−1, (3.13)
0 ≤ lim inf yn ≤ lim sup yn ≤
b e
c(1− d)
(
1
b− 1
− Γ
)
, (3.14)
0 ≤ lim inf zn ≤ lim sup zn ≤
b e
c(1− d)(1 − f)
(
1
b− 1
− Γ
)
. (3.15)
where Γ = min ( (b−1) (1−d) (1−f)b e ,
1
b−1 ).
3.3. Analysis of disease-free and endemic states. We state some theorems that will be of help in the subse-
quent sections and are derived from the theoretical results of Dehghan et al [44, Section 4.2–4.3]. These results
present the local stability of both equilibrium points and the global stability of (3.11).
Theorem 3.3 (See [44], Theorem 4.4). Consider system (3.8)−(3.10) with b > 1, 0 < d < 1, e > 0, and
0 < f < 1. Then the following statements are true.
(i) If Rd < 1 holds, then the equilibrium point (3.11) is asymptotic stable.
(ii) If Rd > 1 holds, then the equilibrium point (3.11) is unstable.
(iii) If Rd = 1 holds, then the roots of the characteristic polynomial at the equilibrium points (
1
b−1 , 0, 0)
and ( 1b−1 , (1 − f)ψ,ψ) are {1,
1
b , d f}.
(iv) The equilibrium point ( 1b−1 , 0, 0) is not a repeller.
Theorem 3.4 (See [44], Theorem 4.7). Consider system (3.8)−(3.10) with b > 1, c > 0, 0 < d < 1, e > 0,
and 0 < f < 1. If the reproduction number Rd is less than unity, then the equilibrium point (
1
b−1 , 0, 0) is
globally asymptotically stable. Therefore the disease can be eradicated from the host.
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Theorem 3.5 (See [44], Theorem 4.5). Consider system (3.8)−(3.10) with b > 1, 0 < d < 1, e > 0, and
0 < f < 1. Then the following statements are true.
(i) If Rd > 1 holds, then the equilibrium point (3.12) is asymptotic stable. In addition, the system has no
equilibrium point in R3>0(= {(x, y, z)| x > 0, y > 0, z > 0}) when c ≤ 0.
(ii) If Rd < 1 holds, then the equilibrium point (3.12) is unstable. In addition, the system has no equilib-
rium point in R3>0 when c ≥ 0.
(iii) The equilibrium point (3.12) is not a repeller.
Theorems 3.3 and 3.5 show that a bifurcation occurs when Rd = 1 (See [44, Corollary 4.6]). On the other
hand, the disease will persist ifRd exceeds unity, where a stable endemic equilibrium exists. This phenomenon,
where the disease-free equilibrium loses its stability and a stable endemic equilibrium appears as Rd increases
through one, is known as forward bifurcation [3, 4, 5, 10]. This pattern was first noted by Kermack and
McKendrick [28], and has been observed in the vast majority of disease transmission models in the literature
ever since (see [10, 15, 16, 35] and the references therein). For models that exhibit forward bifurcation, the
requirement Rd < 1 is necessary and sufficient for disease elimination. Furthermore, these theorems express
that the equilibria (3.11) and (3.12) are not asymptotically stable simultaneously.
Now we give the main question of this work which was given as an Open Problem in [44, Section 4.3].
Hopefully we then show that, based on the parameter set requirement, the conjecture is true.
Open Problem : Show that the positive equilibrium point (3.12) is globally asymptomatically stable if
Rd > 1 along with the following conditions imposed to the paramors:
b > 1, c > 0, 0 < d < 1, e > 0, and 0 < f < 1.
In the first place, we show that the this problem holds under the assumption when e > (b − 1)(1 − d). But
before demonstrating this statement, we need to state the following theorem as things develop.
Theorem 3.6. Let [a1, b1], [a2, b2], and [a3, b3] be intervals of real numbers, and let
fi : [a1, b1]× [a2, b2]× [a3, b3]→ [ai, bi], for i ∈ {1, 2, 3}
be continuous functions. Consider the system of difference equations
xn+1 = f1(xn, , zn),
yn+1 = f2(xn+1, yn, zn), n = 0, 1, 2, ...
zn+1 = f3(yn+1, zn),
(3.16)
with initial conditions (x0, y0, z0) ∈ [a1, b1] × [a2, b2] × [a3, b3]. Suppose that the following statements are
true.
(1) f1(x, z) is non-increasing in z and is non-decreasing in x.
(2) f2(x, y, z) is non-decreasing in x, y, and z.
(3) f3(y, z) is non-decreasing in y and z.
(4) If (mi,Mi) ∈ [ai, bi]
2, for i ∈ {1, 2, 3}, is a solution of the system of equations
mi = fi(m1,m2,m3) and Mi = fi(M1,M2,M3) for i ∈ {1, 2, 3} (3.17)
then m1 = M1,m2 = M2, andm3 = M3.
Then there exists exactly one equilibrium point (x¯, y¯, z¯) of system (3.16) and every solution of system
(3.16) converges to (x¯, y¯, z¯).
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Proof. It is obtained in the same argument as [20, 21]. 
We showed that solutions of system (3.8)−(3.10) are bounded from above in (3.13)−(3.15) (see Theorem
3.2). We now demonstrate that solutions are bounded from below, namely (yn, zn) are away from (0, 0) (this
was already shown for xn).
Theorem 3.7. Assume that e > (b − 1)(1 − d) and (y0, z0) 6= (0, 0) hold. Then every solution of system
(3.8)−(3.10) is bounded from below, i.e. lim inf (xn, yn, zn) > (0, 0, 0).
Proof. It was already shown in (3.13) that xn > 0. One can use equations (3.8)−(3.10) to show simply that
if lim supn→∞ yn or lim infn→∞ zn equals zero, then {yn}
∞
n=0 and {zn}
∞
n=0 converge to zero as well. Now
assume on the contrary that one of the sequences yn or zn converges to zero, then the other one converges to
zero as well. So (xn, yn, zn)→ (
1
b−1 , 0, 0) with yn > 0 and zn > 0 for all n ∈ N. Let ǫ > 0 satisfy
(b− 1)(d− 1) + e− e(b− 1)ǫ ≥ 0, (3.18)
then there is N such that xn is very close to
1
b−1 and for n ≥ N
1
b− 1
− ǫ < xn <
1
b− 1
+ ǫ.
As a result, for n ≥ N ,
yn+1 > dyn + e
(
1
b− 1
− ǫ
)
zn.
Using the fact that zn ≥ yn, we have
yn+1 > dyn + e(
1
b− 1
− ǫ)yn =
(
d+ e(
1
b− 1
− ǫ)
)
yn.
In view of (3.18), we have yn+1 > yn > ... > yN , which is a contradiction. So the desired result follows. 
Now we present one of the main theorems of this work which provide partially an answer to the Open
Problem given in [44] when e > (b− 1)(1 − d).
Theorem 3.8. Assume that e > (b− 1)(1− d) holds. Then the equilibrium point (3.12) of system (3.8)−(3.10)
is globally asymptotically stable.
Proof. It was shown in Theorem 3.5 that the equilibrium point (3.12) of system (3.8)−(3.10) is locally asymp-
totically stable. It is just required to demonstrate that every solution of system (3.8)−(3.10) converges to the
equilibrium point (3.12). We use the result of Theorems 3.6 and 3.7. It follows by Theorem 3.7 that there are
(mx,Mx), (my,My), and (mz,Mz), a solution of (3.17), such that
0 < mx = lim inf xn ≤ xn ≤ lim supxn = Mx, (3.19)
0 < my = lim inf yn ≤ yn ≤ lim sup yn = My, (3.20)
0 < mz = lim inf zn ≤ zn ≤ lim sup zn = Mz. (3.21)
Now if we show that mx = Mx, my = My, and mz = Mz , then we prove the part (4) of Theorem 3.6 and
other parts of this theorem are clearly true. To this end, we substitute (mx,Mx), (my,My), and (mz,Mz) in
system (3.8)−(3.10), it then follows that
mx =
1 +mx
b+ cMz
and Mx =
1 +Mx
b+ cmz
, (3.22)
my = dmy + emxmz and My = dMy + eMxMz, (3.23)
mz = f mz +my and Mz = f Mz +My. (3.24)
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First isolating mx andMx in (3.22) give
mx =
1
b− 1 + cMz
and Mx =
1
b− 1 + cmz
,
we then replace mx andMx in (3.23). Likewise solving (3.23) formy andMy gives
my =
emz
(1− d)(b− 1 + cMz)
and My =
eMz
(1− d)(b − 1 + cmz)
,
and we are now able to generate mz andMz in (3.24),
mz =
emz
(1 − f)(1− d)(b− 1 + cMz)
and Mz =
eMz
(1− f)(1− d)(b − 1 + cmz)
,
which is equivalent to
1 =
e
(1− f)(1− d)(b− 1 + cMz)
and 1 =
e
(1− f)(1− d)(b− 1 + cmz)
.
This shows that mz = Mz , so are mx = Mx and my = My . As a result the assumptions of Theorem 3.6
hold, then there exists exactly one equilibrium point (3.12) of system (3.8)−(3.10) and every solution of system
(3.8)−(3.10) converges to (3.12). 
Theorem 3.9. Consider system of difference equation (3.8)−(3.10) with b > 1, c > 0, 0 < d < 1, e > 0, and
0 < f < 1. Assume that (x0, y0, z0) ∈ R
3
+, then {(xn, yn, zn)}
∞
n=0 converges to (3.11) or (3.12).
Proof. Using Theorems 3.4 and 3.8, it is sufficient to show the argument hold only for
(b− 1)(1− d)(1 − f) < e < (b− 1)(1 − d).
The same reasoning as in the proof of Theorem 3.8 produces system (3.22)−(3.24). If my or mz is zero, say
my, then by (3.9) and the fact that mx is bounded and greater than zero it follows that mz is zero. As a result
by (3.22), we deduce that mx = Mx = 1/(b − 1), hence My = Mz = 0. So the solution converges to (3.11).
If both the lower bounds are strictly greater than zero, the result is given in Theorem 3.8. 
Theorem 3.10. Assume that (b − 1)(1 − d)(1 − f) < e < (b − 1)(1 − d) and (y0, z0) 6= (0, 0) hold. Then
every solution of system (3.8)−(3.10) is bounded from below.
Proof. Assume on the contrary that one of yn or zn converges to zero, the other one converges to zero too, and
then xn →
1
b−1 . Since (b− 1)(1 − d)(1− f) < e, choose ǫ > 0 and l > 0 such that
(1− b)(1− d)(1 − f) + e(1− dl+1)− e(b− 1)ǫ ≥ 0, (3.25)
then there is N such that xn is very close to
1
b−1 and for n ≥ N
1
b− 1
− ǫ < xn <
1
b− 1
+ ǫ.
As a result, for n ≥ N
yn+1 > dyn + eK zn.
where K = ( 1b−1 − ǫ). Let zi,l = min{zi, zi−1, ..., zi−l}, then by (3.25) it follows that
zn+1 > fzn + eK zn + dyn > fzn + eKzn−l + eK dzn−l + ...+ eKd
lzn−l + d
lyn−l
> (f + eK + eK d+ ...+ eKdl)zn,l + d
lyn−l
>
(
f + eK
(
1− dl+1
1− d
))
zn,l.
Then by induction on n, it follows that
zn+T > ... > zn+2,l > zn+1,l > zn,l
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which is a contradiction. So the desired result obtains. 
The following theorem is the main result of this research which answers to the Open Problem given in [44].
Theorem 3.11. Assume that e > (b − 1)(1 − d)(1 − f) holds. Then the equilibrium point (3.12) of system
(3.8)−(3.10) is globally asymptotically stable.
Proof. It follows from Theorem 3.10 and the argument of Theorem 3.8. 
4. INFERENCE IN CONTINUOUS HIV INFECTION MODEL WITH CORRELATED DYNAMIC DISCRETE MODEL
This section develops a reliable comparison for the original continuous HIV infection model, system (2.1)–
(2.3), with estimation of correlated dynamic discrete model, system (3.8)−(3.10). Inference in dynamic discrete
model involves computing the solutions to a high-dimensional system and analyzing theoretically the long-term
behavior of solutions. The parameter values used for the numerical scheme, system (3.8)−(3.10), are derived
technically by employing the change of variables in Section 3.2, given as follows,
b = 1 + lγ1, c = −le1, d =
1
1 + l e3
, e =
l3 s e2e4
(1 + l e3)(1 + l σ)
, and f =
1
1 + l σ
from which it follows that b > 1, c ∈ R, 0 < d < 1, e > 0, and 0 < f < 1 when l > 0. The parameter values
for the continuous HIV infection model, system (2.6), were correspondingly chosen by (2.4) in Section 2 and
the change of variables (2.5) so that all the possible observed steady states (x¯, y¯, z¯) were identified clearly by
τ = γ1, ρ =
e2 e4 s
e3 γ1
, ζ = e3, and η = σ.
The chain convergence is checked by comparing the estimation results for several different parameter values
in Theorems 3.3 and 3.5 with the results of [8, Theorem 2.1] or [14, Section 4]. Surprisingly, we observe
that the local behavior of solutions of the continuous HIV infection model is qualitatively similar to that of
numerical scheme for discrete model corresponding to the same parameter set, since the conditions Rd =
e
(b−1) (1−d) (1−f) > 1, Rd = 1, or Rd < 1 are equivalent to Rc =
s e2 e4
σ γ1 e3
> 1, Rc = 1, orRc < 1 respectively.
In addition, the conditions d < b, d = b, and d > b are equivalent to σ γ1 e3 < s e2 e4, σ γ1 e3 = s e2 e4,
and σ γ1 e3 > s e2 e4, respectively. Therefore, Theorems 2.1, 3.4, and 3.9, and Corollary 4.3 in [44] show
that global dynamics of these models are considerably equivalent for e1 < 0 which is related to c > 0. The
estimation results for the correlated dynamic discrete model are only slightly affected by the fixed time step
size l, see Subsection 5.1. Such a case scenario shows that the numerical scheme (3.3) is an efficient algorithm
in conjunction with e1 < 0 and suitable for use to solve the dynamic continuous HIV infection model.
The following results are motivated by the stage estimation procedure in which the key parameter c is taken
to be zero, that is, c = 0 corresponding to e1 = 0 for the dynamic continuous model. In fact, these results are
provided by Theorem 2.2 in [8] (proved for the continuous model) and Theorem 4.2 and Corollary 4.3 in [44]
(proved for the discrete model). The paper studies theoretically the estimation method’s performance in the
case when e1 = 0 or c = 0. The findings demonstrate that the estimation accuracy of the proposed numerical
method is excellent since similar results for both models are achieved.
However, the main difference appears in the qualitative behaviors of solutions of the models when e1 >
0. Theoretical results and several experiments on artificial data and parameter values show that the dynamic
discrete model conducted by the estimated method and the continuous model with HIV infection can behave
quite differently when e1 > 0. More generally, the experiments demonstrate that system (2.6) can attain
bounded or unbounded solutions [8] while the qualitative behavior of system (3.8)−(3.10) with different initial
values can lead to dispersion and serious misspecification errors referred to as forbidden sets, see Appendix
A. The proposed theoretical framework for system (2.6) is flexible and leaves room for experimentation and
abstract results. Experiments with the numerical estimation algorithm for solving system (3.8)−(3.10) requires
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TABLE 2. Effect of time step, l, on the convergence of the methods using c = 3.1 [14].
l RK4 Method A
0.001 Convergence Convergence
0.01 Divergence Convergence
10 Divergence Convergence
200 Divergence Convergence
a discovery of modifications and development of the numerical method in our future work that will hopefully
provide a very efficient alternative to iterating the approximation (3.3) for negative parameter c. The most
important reason for this difference seems to be, a great deal, based on forward-difference approximation (3.3).
5. NUMERICAL EXPERIMENTS
A verification of the algorithm implementation for the above scenario cases is provided in this section. For
example, the effect of different parameter values for time-step and immune response to the proposed estimation
algorithm (3.3) are studied to identify an effective treatment for the management of HIV infection administrat-
ing multiple anti-HIV preventive drugs in vivo. Multiple parameter sets are used to check the convergence of
the estimation procedure in which solving the exact solution of model (2.6) can be quickly computed. Also
several examples show that with different initial values (x0, y0, z0) ∈ R
3
+, solutions of (3.8)−(3.10) attain neg-
ative values. However, theoretical results are provided to show that some solutions of system (2.6) remains in
R
3
+ whenever (x0, y0, z0) ∈ R
3
+ in Appendix A.
5.1. Effect of time-step, l. We will show that the associated numerical estimation method is very robust in
terms of numerical stability since the equilibria and the stability conditions are independent of the time step
by detailed comparisons. Several numerical simulations were carried out using the numerical method (3.3),
regarded as Method A in Table 2, to identify the behavior of solutions of the model (3.8)−(3.10) with various
time steps. An intuitive comparison of the results obtained from the application of the fourth-order Runge-
Kutta method (RK4) and Method A is depicted in Table 2 from which it is obvious that numerical scheme
(3.3) is more competitive in connection with numerical stability. Extensive numerical simulations performed
by the numerical approximation (3.3) show that Method A did not provide solutions with chaotic behavior [14].
In fact, every solution of estimation method converges either to the disease-free state or endemic state. This
scenario was given by some numerical examples in [14] without any theoretical proof.
Interestingly the equilibrium point of system (3.4)−(3.6), say (T¯4, T¯I , V¯I) = (aˆ x¯, y¯/gˆ, z¯), is independent of
the time step, that is, the solution approaches to the disease-free or endemic equilibrium point of the original
model given by the system of ordinary differential equations (2.1)−(2.3) or system (2.6). As a result, regardless
of the implementation of time step, a unique equilibrium point is eventually obtained. It is also shown in
Theorems 3.4 and 3.11 that the solution obtained by the numerical scheme approaches to the disease-free
or endemic equilibrium point, whether the reproduction number Rd is less than or in excess of unity. The
demonstrations are independent of variation of l as long as l > 0. Using the previous discussion and dynamical
comparison of Section 4, the solution likewise converges to the equilibrium point for sufficiently small values
l (0 < l << 1) and is, as a result, consistent with the compartmental model (2.1)−(2.3).
5.2. Effect of basic reproduction number, Rd. Here we attempt to determine appropriately the dynamics
of discrete model by the sensitive quantity threshold, Rd, keeping the immune response to a sufficient level.
A reliable comparison of the estimation results for the proposed numerical approximation (3.3) suggests that
CONTINUOUS AND DISCRETE DYNAMICS OF HIV INFECTION 13
a qualitative behavioral change to the model appears through destabilizing the disease-free equilibrium and
emergence of a stable endemic equilibrium. A stable endemic equilibrium branch appears with an unstable
disease-free equilibrium (leading to the persistence and existence of HIV within the infected individual) when
the related reproduction number is less than one. The attractivity of the model reveals that the disease-free
equilibrium is globally asymptotically stable under certain assumptions. Nevertheless the unique endemic
equilibrium is globally asymptotically stable in the presence of 60% effective combination therapy. In addition,
a comparison between the discrete and continuous models is presented to have a better view in understanding
the behavioral dynamics of HIV infection modelling.
The correlated dynamic discrete model may exhibit a threshold behavior of a possibility of sustained oscil-
lations. Oscillations in the model mean fluctuations in the number of uninfected/infected/infectious cells to be
expected and the HIV infection still persists but in an oscillatory manner for certain parameters values. The
model (3.8)−(3.10) suggests that the presence of damped oscillations is inevitable to emerge if the threshold
distinguished as the basic reproduction number is maintained above a certain quantity during therapy. This
includes the possibility that the presence of certain parameter values can destabilize the endemic equilibrium
point of the model with constant coefficients and lead to sustain damped oscillations for the reproduction num-
ber exceeding a threshold value. Such a change in behavioral dynamics of infection is considerably affected
by the insufficient level of CTL response in the immediate surroundings of antiretroviral therapy with relapse.
Clearly a higher magnitude of basic reproduction numbers inferred from both continuous HIV infection model
and dynamic discrete model is related to a comparatively lower threshold level of immune response or ineffec-
tive combination of reverse transcriptase and protease inhibitors in vivo.
Numerical simulations, Figure 2, indicate that transitory oscillations are observed for about the first 100 units
of time and no sustained oscillations are obtained when the endemic equilibrium point appears to be stable for
lower values of Rd close to unity, Rd ≥ 1, but not for significantly large values. As the threshold level of basic
reproduction number exceeds unity and is maintained above a certain threshold, the time periods of oscillations
to the solutions of the model become shorter and rapid in conjunction with occurrence of higher amplitudes of
oscillations.
Comparison of the two rows in Figure 2 for two different parameter values c = 0.6, 0.006 shows that
the magnitude of maximal density for the activated CD4+ T cells carrying integrated HIV (infected cells)
and density of virus particles is overwhelmingly larger in the top array corresponding to smaller value, c =
0.006, while the estimation results for the density of uninfected cells are only slightly affected by the same
parameter values. Surprisingly, the qualitative oscillatory behavior of the correlated dynamic discrete model
is not substantially perturbed by the implementation of various parameter values for c. This result seems
to have a simple explanation. The expected long-term solution of the model (3.8)−(3.10) associated with
the equilibrium point (3.12) is intuitively sensitive to the implementation of the parameter c and the basic
reproduction number. The larger the parameter value c, the higher amplitude is observed for the density of
infected cells and virus particles, Figure 2. However the parameter value c produces directly no sizeable effects
or possible repercussions to the density of uninfected cells.
5.3. Effect of immune response, kc. The effect of the CTL (cytotoxic T lymphocyte) response was investi-
gated [14] by simulating Method A with various values of the CTL response parameter, kc, in the absence of
therapy (that is ERT = EPI = 0). The steady-state values of the corresponding viral loads are given in the
following table. Another experiment was carried out to monitor kc when combination therapy is 60% effective
(ERT = EPI = 0.6) and the results are tabulated in Table 3. It is worth mentioning that such limited efficiency
of combination therapy (60%) may occur due to many reasons, including sub-optimal usage of the regimen,
poor compliance, poor absorption of certain drugs, mutation, etc.
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TABLE 3. Effect of CTL response, steady-state values of infectious viral load (density of HIV) [14]
kc Effect of CTL response in the absence of effective
protease inhibitors where ERT = 0
Effect of CTL response in the presence of 60% combi-
nation therapy
0.0 834.90 588.11
0.6 376.77 254.93
1.0 274.97 180.89
5.4. Combination antiretroviral therapy versus monotherapy. In this experiment, we make use of the
mathematical discrete model (3.8)−(3.10) to identify an effective treatment strategy for the management of
HIV infection using multiple anti-HIV preventive drugs in vivo. Figure 3 describing the within-host infectious
dynamics provide us an intuitive comparison for both combination antiretroviral therapy and monotherapy us-
ing the quantity threshold Rd =
s e2 e4
σ γ1 e3
related to the set of parameter values s = 8.076, r = 0.03, kv = 1,
γ1 = 0.5, γ2 = 0.5, N = 1000, L = 0.2, σ = 10 and multiple sets of variables (ERT , EPI , α). For
the monotherapy experiment, we assume that only protease inhibitors, e.g. nelfinavir, are administered to the
HIV-infected patient [14, Section 6.3]; thus the horizontal axis as a variable is used for the effectiveness values
FIGURE 2. Estimated densities of (x¯, y¯, z¯) in conjunction with (T¯4, T¯I , V¯I) are arranged horizontally for
two different parameter values; c = 0.6 is taken into account for the densities located on the top array and
c = 0.006 is considered for the densities on the bottom row. The accumulated densities corresponding to unin-
fected/infected/infectious cells are plotted for a range of different threshold levels of the basic reproduction number,
Rd ∈ [0.13344, 100]. The lower densities related to lower horizontally shaded strips are obtained from the rela-
tively high threshold level of immune response along with the effectiveness of reverse transcriptase and protease
inhibitors, that is, Rd ≤ 1. The innermost strips with tardily transitory oscillations are illustrated for the threshold
level of basic reproduction number exceeding unity, but not for significantly large values of Rd. While the rela-
tively large magnitude of Rd may exhibit a threshold behavioral change which may result in generating sustained
oscillations of the uninfected/infected/infectious cells.
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E = EPI with ERT = 0. Note that a similar experiment can be illustrated by assuming ERT as variable with
EPI = 0. As the administration of a combination of two or more drugs to the HIV-infected patient is currently
a treatment strategy [14, Section 6.3], another experiment with respect to the combination therapy is conducted
with an equivalent administration of both reverse transcriptase and protease inhibitors, that is, we assume that
the horizontal axis as a variable represents the effectiveness values E = EPI = ERT . In both experiments,
vertical axes represent the effect of the CTL (cytotoxic T lymphocyte) response. The black/gray/white shaded
areas are used for various values of pre-existing activated CD4+ T cells, 0 ≤ α ≤ 1. The basic reproduction
number is in excess of unity in each corresponding area with the stated value α and including the area(s) with
lower values of α. For instance, the basic reproduction number for α = 0.1 not only represents the correspond-
ing shaded area but also includes the areas with α = 0, 0.01.
In both scenarios, further computational experiments of the model for an enhanced comparison are performed
on the representation of 60% and 80% effectiveness of therapy with 50% and 75% immune response. In each
set of these independent experiments, four distinguishable horizontal and vertical dashed lines are drawn on the
shaded areas for this model, see Figure 3. These experimental results are intriguing. Using both experiment
presented in Figure 3, clearly the chance to suppress the viral load is so narrow for monotherapy, in some
cases less than one percent and it may be interpreted as impossible, while combination therapy provide better
confidence in removal of integrated HIV cells. For instance, the experimental analysis on the model with
administration of only protease inhibitors refereed as monotherapy indicates that the basic reproduction number
is greater than one for the ordered pair (0.6, 0.5) with a proportion α ≥ 0.01 of pre-exiting activated CD4+ T
cells, that is, the virus load cannot be entirely inhibited in the presence of 60% effective monotherapy at 50%
effective immune system or more. In contrast, the suppression of virus load in the patient is likely to occur for
α ≤ 0.1 by implementing the same experiment using 60% effective combination therapy in the presence of
more than 90% effective immune system.
Second analysis on the model may be performed in the immediate surroundings of 80% effective monother-
apy and combination therapy to a HIV-infected patient. The findings, based on simulations for the correlated
dynamic discrete model, suggest that the combination therapy is greatly efficient in mitigating the infectious
viral load with a possibility of successful suppression for the proportion α ≤ 0.5, since in this case Rd will be
equal or inferior to one. On the contrary, by administrating only protease inhibitors in a similar experiment, the
infectious virus is most likely to persist within an infected individual if α ≥ 0.1. The amount of viral load is
not sufficiently reduced to a certain extent required for Rd < 1.
Alternatively, to further verify the possibility of successful persistence or inhibition of infectious viral load
in a patient, we conduct this experiment with a proportion value of pre-exiting activated CD4+ T cells close to
unity to perturb the dynamics of the HIV model, these experimental results are also intriguing. To control and
bring down the volume of viral load for monotherapy scenario, it is required to monitor treatment not less than
99% effective, and in some cases it is impossible to mitigate HIV risk in vivo. However the consequence of
administrating two drugs is a success for mitigation and prevention of infectious virus load using antiretroviral
treatment that is 90% effective or more if α is close to one.
Besides, Table 4 depicts the steady-state values of the viral load with multiple parameter values for the effec-
tiveness of the inhibitors (RT and PIs). In the numerical simulation, identical efficiency levels were conducted
for the management of HIV infection in vivo using the mathematical model (3.8)−(3.10) [14]. It is clearly
illustrated that as the efficiency level of the drugs is increased, the infectious virus density decreases. With the
administration of 99% effective combination therapy (that is, ERT = EPI = 0.99), however, the two steady
states exchange their stability, and the virus particle density converges to zero [14]. The endemic equilibrium
loses its stability and a stable disease-free equilibrium appears as the basic reproduction number falls behind
unity. In such a scenario, the associated reproduction number being inferior to unity becomes a necessary and
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sufficient condition for disease elimination to the HIV-infected patient. This result is, of course, consistent with
the theoretical analysis of previous sections.
TABLE 4. Effect of combination therapy: steady-state values [14]
EPI ERT V¯I
0.2 0.2 356.44
0.6 0.6 282.69
0.99 0.99 0
5.5. Identification of regions for incompatible estimated densities. Our objective here is to identify regions
where solutions generated from the numerical estimation for the correlated with dynamic discrete model is
inconsistent with the behavior of solutions of the continuous HIV infection model. Based on the description
of parameters in HIV model and their estimated values presented in Table 1, incompatible iterative solutions is
most likely to be generated in the regions when the key parameter e1 is positive. As discussed previously, the
estimated parameter c can hold negative values conjunction with positive values for e1.
In order to get more insight into the effects of the key parameter c on the perturbation of the solution, we
conducted another experiment using the function ERT =
α
α+r for the effectiveness of reverse transcriptase
inhibitors proportional to the pre-existing activated CD4+ T cells, α. In Figure 4, we observe that the effec-
tiveness of reverse transcriptase inhibitors decline as the magnitude of the rate of proliferation of CD4+ T cells
is increased from 0 to 1. Hence this can significantly reduce the area where e1 can be positive shrinking the
regions of incompatible iterative solutions for numerical estimations.
FIGURE 3. A comparison between effectiveness of antiretroviral monotherapy versus combination therapy us-
ing the quantity threshold Rd =
s e2 e4
σ γ1 e3
is studied in this experiment related to the multiple sets of variables
(ERT , EPI , α). The horizontal and vertical axes are used for monotherapy or combination therapy, and the effect
of CTL response respectively. Based on simulations and theoretical results, an effective treatment strategy for the
removal of integrated HIV cells is identified by the administration of combination therapy. From both experiments,
we observe that the possibility of survival of viral load using monotherapy is more than 99% for some HIV-infected
patients while it can be broadly reduced to 80% by intervention of both ERT and EPI .
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6. CONCLUSION
This paper presents a method for analogy in continuous HIV infection model, system (2.1)–(2.3), with esti-
mation of correlated dynamic discrete model, system (3.8)−(3.10). We primarily construct the compartmental
model of HIV infection for three different cell types, i.e. susceptible, infected, and infectious categories. The
model simulates the interaction between CD4+ T cells and HIV in vivo when combination antiretroviral ther-
apy is used for the management of infection. Basically, reverse transcriptase inhibitors and protease inhibitors
are exerted for the perturbation of HIV. Developing the robust numerical method 3.3, we can successfully iden-
tify dynamics of behavioral changes in solutions of non-denationalized system (3.8)−(3.10) by the quantity
threshold Rd. A complete proof for the convergence of the proposed estimation solutions to the endemic equi-
librium point is obtained for the Open problem given in [44, Section 4.3] with the assumptions imposed to the
set of parameter values. The findings show that the burden of characterizing dynamics of the continuous HIV
infection model (2.1)–(2.3) can be reduced to the computational discrete model at each iteration by efficient
use of the estimation algorithm 3.3 and the information obtained on previous stages.
Next a reliable comparison for the original deterministic HIV infection model with correlated dynamic dis-
crete model is studies to analyze theoretically the long-term and oscillatory behavior of solutions. The results
demonstrate that the estimation accuracy of the proposed numerical method is an efficient algorithm for solving
the dynamic continuous model in conjunction with e1 ≤ 0, since similar results for both models are achieved.
The main difference turns out to be in the qualitative behaviors of solutions of the models when e1 > 0.
Theoretical results and extensive experiments on artificial data with multiple sets of parameter values show
that the discrete model conducted by the computational method conducted can behave quite different with
the continuous deterministic model with HIV infection when e1 > 0. Roughly speaking, the experiments
demonstrate that system (2.6) can attain bounded or unbounded solutions [8] while the qualitative behavior
of system (3.8)−(3.10) with different initial values can lead to serious misspecification errors referred to as
forbidden sets, see Appendix A. In analysis of system (3.8)−(3.10), the paper establishes the complete con-
vergence of the solutions to the nonnegative equilibrium points depending on the quantity threshold Rd; it
then follows that no bistability occurs to the solutions and a forward bifurcation is observed when the equality
e = (b− 1)(1 − d)(1− f) hold.
FIGURE 4. A comparison analysis for different values of the rate of proliferation of CD4+ T cells. The param-
eter e1 (c, respectively) can be positive (negative) in the area delimited by each curve, ERT−axis and the constant
value ERT = 1. Different curves are generated by the function ERT =
α
α+r
with respect to the proportion of
pre-existing activated CD4+ T cells, α, for r = 0, 0.03, 0.2, 0.8, respectively.
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The theoretical results follow by implementation of several experiments with respect to numerical algorithm
to verify, among other things, the effect of multiple parameter values for time-step and immune response. For
instance, we show that the numerical method was a very robust and efficient technique in terms of stability
to solve the continuous HIV infection system for large/small time steps since the equilibria and the stability
conditions are independent of the time step. This was claimed without theoretical results by Gumel et al. [14].
Numerical simulations also indicate that transitory oscillations are observed for about the first 100 time units
and no sustained oscillations are observed when the endemic equilibrium point appears to be stable for lower
values of Rd close to unity but not for significantly large values. However, the time periods of oscillations to
the solutions of the model become shorter and rapid in conjunction with occurrence of higher amplitudes of
oscillations when the threshold level of basic reproduction number exceeds unity and is maintained above a cer-
tain threshold sufficiently large. Besides, we observe that the qualitative oscillatory behavior of the correlated
dynamic discrete model is not substantially perturbed by the implementation of various parameter values for c.
Further computational experiments are performed for the within-host infectious model in order to identify
an effective treatment strategy for the control of HIV infection by application of single/multiple anti-HIV pro-
phylactic medications within a patient. An intuitive comparison for both combination antiretroviral therapy
and monotherapy is described for several case studies using multiple sets of variables (ERT , EPI , α). We
subsequently study the possibility of successful persistence or inhibition of infectious viral load. In fact, we
conduct these experiments to investigate the qualitative effect of various proportion values of pre-exiting acti-
vated CD4+ T cells through perturbation of dynamics of the HIV model. To control and bring down the volume
of viral load for monotherapy scenarios, the findings suggest that, in some cases, it is impossible to mitigate
HIV risk in vivo, or it is required to monitor antiretroviral treatment that is 99% effective or more. However
the consequence of administrating two drugs is a success for mitigation and prevention of infectious virus load.
Especially, if α is close to one, the virus particles can be significantly inhibited in the presence of only 90%
effective combination therapy.
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APPENDIX A. DYNAMICS OF SOLUTIONS WITH NEGATIVE PARAMETER c
In this section, c is considered a negative number. As we will see in the next section, this situation is
equivalent to e1 > 0 in the continuous model.
In this case we have again two equilibrium points (3.11) and (3.12). But the equilibrium point (3.12) has
negative components, i.e. y¯ and z¯, while (3.12) is locally asymptotically stable (Theorem 3.5). However, if we
can show that the solution eventually enters a negative area of R3, then viral load can be suppressed from the
host.
Theorem A.1. The following statements are true:
(i) Assume that x0 ≥ −1, y0 = 0, and z0 = 0, then xn > 0, yn = 0, and zn = 0.
(ii) Assume that x0 ≥ −1, y0 < 0, and z0 <
−b
c , then xn ≥ 0, yn < 0, and zn < 0.
Proof. The proof is an obvious result of system (3.8)−(3.10). 
Now if we multiply the second and third equations of system (3.8)−(3.10) by −1, the change of variables
Xn = xn, Yn = (−yn), Zn = (−zn) gives system (3.8)−(3.10) with c substituted by (−c) which is positive in
the first equation, and then we have {(Xn, Yn, Zn)}
∞
n=1 ⊂ R
3
+. As a result, the dynamic of the solution when c
is negative with x0 ≥ −1, y0 < 0, and z0 <
−b
c is exactly the same as the positive case.
For other situations, it is not possible to verify the dynamics of solutions, since it is difficult to find the
forbidden set F, the set of initial conditions (x0, y0, z0) ∈ R
3 through which the denominator (b + czn) in
equation (3.8) will become zero for some value of n ≥ 0. Note that the situation c < 0, x0 ≥ −1, y0 < 0, and
z0 <
−b
c in (3.8)−(3.10) corresponds to e1 > 0, x0 ≥ 0, y0 < 0, and z < 0 in the continuous model (2.6).
However we can leave a conjecture here that with an initial solution in this form (x0, y0, z0) ∈ R
3\F, the
solution will become eventually as follows:
xn ≥ 0, yn ≤ 0, and zn ≤ 0.
A.1. Sensitivity analysis for negative parameter experiments.
Example A.2. In order to test the stability and convergence properties of the scheme constructed in Sections
5.4, 5.5, and 5.6, we use the method to simulate the model (3.8)−(3.10) with the initial values and parameter
(x0, y0, z0) = (1, 0, 10
−10), b = 2, c = −1, d = 0.5, e = 1, and f = 0.5.
We have clearly that e > (b − 1)(1 − d)(1 − f), therefore, the equilibrium point, (0.25,−1.5,−3), is
locally asymptotically stable. Table 5 illustrates the global asymptotical stability of the equilibrium point
(0.25,−1.5,−3).
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TABLE 5. Negative parameter together with positive initial values leads to negative solutions, that is, a
small portion of viral load can be suppressed immediately.
n Density of xn Density of yn Density of zn
0 1 0 10−10
10 1.000000015 0.2955390683 × 10−7 0.4037138739 × 10−7
50 0.2502325578 −1.499534885 −2.997932087
100 0.2500000000 −1.500000000 −3.000000000
Example A.3. In this example, we assume b = 5, c = −1, d = 0.2, e = 1, and f = 0.5. We consider two
solutions of (3.8)−(3.10) with respect to two initial values (0.4, 0.75, 1.5 + 10−5) and (0.4, 0.75, 1.5 − 10−5).
We observe that e < (b − 1)(1 − d)(1 − f), therefore, the equilibrium point, (0.25, 0, 0), is locally asymp-
totically stable. Tables 6 and 7 illustrate the global asymptotical stability of the equilibrium point (0.25, 0, 0).
With the initial value (0.4, 0.75, 1.5 + 10−5), yn and zn are negative after finite iterations. While for the initial
value (0.4, 0.75, 1.5 − 10−5), each component of (xn, yn, zn) is positive.
TABLE 6. Positive initial values and negative parameter converges eventually to zero but not inside the first octant.
n Density of xn Density of yn Density of zn
0 0.4 0.75 1.5 + 10−5
20 0.4000775562 0.7503877812 1.500649000
100 0.2499950251 −0.2487438382 × 10−4 −0.6262803901 × 10−4
200 0.2500000000 −0.1879485081 × 10−12 −0.4732063579 × 10−12
TABLE 7. Negative parameter and positive initial values leads to positive solutions, that is, the viral load
can still persist. One may compare this result with Table 6.
n Density of xn Density of yn Density of zn
0 0.4 0.75 1.5− 10−5
20 0.3999225278 0.7496126391 1.499351619
100 0.2500297591 0.1487952268 × 10−3 0.3746036600 × 10−3
200 0.2500000000 0.1124473755 × 10−11 0.2831137823 × 10−11
